European Drug Seizures Criticized in International Report

EU trade policies regulating the pharmaceutical industry, including the seizure of generic drugs in transit to developing countries, are supporting the commercial interests of some drugmakers while damaging opportunities for innovation and access to medicines in developing countries, an Oxfam International and Health Action International report says. The report criticizes recent European customs authorities’ seizures of generic drugs suspected of infringing intellectual property rights.
International Pharmaceutical Regulatory Monitor